Influenza vaccine, inactivated, surface antigen, Ph.Eur Formulation 2008-2009
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza vaccine, inactivated, surface antigen, Ph.Eur Formulation 2008-2009, covering 2012-01-05 to 2012-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects [Phase 2]